Viz AAA vs VX1+
AI Verdict
Choose Viz AAA if…
Choose Viz AAA if your primary goal is to rapidly detect and triage suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. This tool is ideal for emergency departments and radiology practices aiming to accelerate diagnosis, streamline care coordination, and facilitate timely intervention for AAA patients.
View Viz AAA →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist seeking real-time AI-powered assistance during cardiac ablation procedures for atrial fibrillation or atrial tachycardia. This software is best suited for enhancing the precision of identifying abnormal electrograms and guiding ablation strategies within existing EP lab recording and 3D mapping systems.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz AAA | VX1+ |
|---|---|---|
| Pricing | Subscription model | Unknown |
| Deployment | Cloud-based | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz AAAViz AAA emphasizes integration into existing hospital workflows, real-time alerts, a HIPAA-compliant communication platform, and mobile access to imaging and patient information. These features enhance accessibility and collaborative use across multidisciplinary care teams, extending beyond a single procedural setting. VX1+ focuses on a simple, color-coded interface for a specialized procedural setting, which is intuitive but less broadly applicable for care coordination.
Clinical Value
TieBoth tools are FDA-cleared and provide significant clinical value in their respective specialties. Viz AAA is the first FDA-cleared AI solution for AAA detection and triage, aiming to accelerate diagnosis and improve outcomes. VX1+ offers real-time AI-driven insights to assist electrophysiologists during complex cardiac ablation procedures, directly impacting procedural efficacy.
Pricing & Value
TieNeither Viz AAA nor VX1+ provides publicly available pricing details. Viz AAA uses a subscription model with an annual fee based on algorithms and population size, while VX1+'s pricing is not publicly disclosed. Without transparent pricing, it is impossible to compare their value propositions directly.
Enterprise Readiness
Viz AAAViz AAA explicitly states cloud-based deployment, HIPAA compliance, and the availability of a Business Associate Agreement (BAA). It is also part of a comprehensive AORTIC Module, indicating a robust and scalable enterprise solution. VX1+ deploys as a software application, and while HIPAA compliance and BAA are expected, they are not explicitly stated in the provided facts, suggesting less documented enterprise-level features.
Innovation
TieBoth tools demonstrate significant innovation in their fields. Viz AAA is notable as the 'first FDA-cleared AI-powered solution' for AAA detection and triage, marking a pioneering achievement. VX1+ provides highly advanced, real-time AI-driven insights to guide electrophysiologists during complex cardiac ablation procedures, which is a cutting-edge application of AI in a live surgical environment.
Support & Docs
Viz AAAViz AAA offers a dedicated customer success team, 24/7 urgent phone and email support, a comprehensive Help Center with troubleshooting and tutorials, user guides, and a transparent Trust Center for compliance documentation. VX1+ primarily highlights Instructions For Use (IFU) and a User Manual, along with an 'AI for Persistent AF Care program' for resources, but lacks the extensive, publicly detailed support infrastructure of Viz AAA.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz AAA | VX1+ |
|---|---|---|
| Primary Use Case | Detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. | Assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Company | Viz.ai | Volta Medical |
| Target Specialties | Emergency Medicine, Radiology, Vascular Surgery | Cardiology |
| Key AI Functionality | AI-powered automatic detection of suspected AAA from CTA scans; Automated triage and prioritization of cases. | Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart; Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures. |
| Care Coordination/Workflow Features | Integration into existing hospital workflows; Real-time alerts to care teams; HIPAA-compliant communication platform for multidisciplinary teams; Mobile access to high-fidelity imaging and patient information. | AI-driven insights to assist electrophysiologists during ablation procedures; Simple user interface with color coding for electrogram dispersion; Booster mode for increased sensitivity; Provides cycle length estimation from electrograms. |
Videos
Demos, reviews, and walkthroughs featuring Viz AAA and VX1+.